[1]adeyemi-fowode, o., & stambough, k. c. (2022). general approaches to medical management of menstrual suppression. obstetrics and gynecology, 140(3), 528-541.
[2]hillard, p. a. (2014). menstrual suppression: current perspectives. international journal of women's health, 6, 631.
[3]kaunitz, a. m. (2000). menstruation: choosing whether… and when. contraception, 62(6), 277-284.
[4]jain, v., & wotring, v. e. (2016). medically induced amenorrhea in female astronauts. npj microgravity, 2(1), 1-6.
[5]polis, c. b., hussain, r., & berry, a. (2018). there might be blood: a scoping review on women’s responses to contraceptive-induced menstrual bleeding changes. reproductive health, 15(1), 1-17.
[6]mao l, xi s, bai w, yao c, zhou y, chen x, sun y. menstrual patterns and disorders among chinese women of reproductive age: a cross-sectional study based on mobile application data. medicine (baltimore). 2021 apr 23;100(16):e25329.
[7]mao l, bai w, huo y, et al. cross-sectional study of contraceptive use among chinese women of reproductive age: results based on a mobile application (app)-derived data. arch gynecol obstet. 2018;297(5):1193-1199.
[8]teichmann a, apter d, emerich j, et al. continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. contraception. 2009;80(6):504-511. doi:10.1016/j.contraception.2009.05.128
[9]复方口服避孕药临床应用中国专家共识专家组.(2015).复方口服避孕药临床应用中国专家共识. 中华妇产科杂志(02),81-91.